Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound anti-inflammatory medicine

A compound anti-inflammatory drug and anti-inflammatory drug technology, applied in antipyretics, anti-inflammatory agents, digestive system, etc., can solve problems such as easy recurrence, gastric organ damage, side effects, etc., achieve significant curative effect, regulate immune function, and enhance immunity force effect

Inactive Publication Date: 2017-06-23
张东承
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current anti-inflammatory drugs have the following deficiencies: the drug effect is slow, especially for patients with severe inflammation; there are side effects, which will cause a certain degree of damage to other organs such as the stomach
It treats general oral ulcers, acne, and delayed swelling and pain, and it is easy to relapse after a long time. The total cure rate is 30-50%. For intractable oral ulcers and acne, some people cannot be completely cured for several months or years. cause great pain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A complex anti-inflammatory drug including B vitamins 2 0.1g, vitamin C 0.1g, zinc gluconate 0.075g, prednisone acetate 0.1g, erythromycin 0.3g: various raw materials are pulverized into fine powder, after mixing uniformly, powdery compound anti-inflammatory drug is obtained; The powdery compound anti-inflammatory drug of the present invention is packed into hard capsules and made into capsules according to the conventional process method, and the specification is every 0.5g.

Embodiment 2

[0028] A complex anti-inflammatory drug including B vitamins 2 0.15g, vitamin C 0.15g, zinc gluconate 0.1g, prednisone 0.15g, erythromycin 0.45g; various raw materials are pulverized into fine powder, after mixing uniformly, powdery compound anti-inflammatory drug is obtained; then the obtained Powdered compound anti-inflammatory drugs are packed into hard capsules to make capsules according to the conventional process, and the specification is 0.5g per capsule.

Embodiment 3

[0030] A complex anti-inflammatory drug including B vitamins 2 0.2g, vitamin C 0.1g, zinc gluconate 0.09g, prednisone 0.2g, erythromycin 0.5g; various raw materials are pulverized into fine powder, after mixing evenly, powdery compound anti-inflammatory drug is obtained; then the obtained Powdered compound anti-inflammatory drugs are packed into hard capsules to make capsules according to the conventional process, and the specification is 0.5g per capsule.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound anti-inflammatory medicine. The compound anti-inflammatory medicine is prepared from the following raw materials in parts by weight through crushing and then mixing: 0.1 to 0.2 part of vitamin B2, 0.1 to 0.2 part of vitamin C, 0.075 to 0.15 part of zinc gluconate, 0.1 to 0.2 part of prednisone acetate and 0.3 to 0.6 part of erythromycin; the anti-inflammatory medicine prepared from the five raw materials is mainly used for common people; aiming at old people with poor constitution, 0.2 to 0.6 part of royal jelly powder is further added. All the raw materials are crushed according to a ratio into fine powder, and the fine powder is uniformly mixed to prepare capsules or tablets. The compound anti-inflammatory medicine provided by the invention has the effects of diminishing inflammation, clearing away internal heat and removing damp toxin, and has remarkable curative effects on oral ulcer, refractory oral ulcer, ozostomia, swollen and sore throat, pyogenic pharyngitis, amygdalitis and acnes. The compound anti-inflammatory medicine can be used for regulating a human immunological function, enhancing of the immunity of organisms and supplementing vitamins needed by the human body.

Description

technical field [0001] The invention relates to a compound anti-inflammatory drug, which has remarkable curative effect on oral ulcer, intractable oral ulcer, bad breath, sore throat, suppurative pharyngitis, tonsillitis and acne. Background technique [0002] Anti-inflammation refers to drugs that inhibit the production or release of inflammatory factors. By inhibiting the production of inflammatory factors, the inflammation can be reduced or subsided, and at the same time, the pain caused by inflammation can be relieved. Normally, inflammation is beneficial and is an automatic function of the human body. defense response, but sometimes, inflammation is also harmful, such as the attack on the body's own tissue, inflammation in transparent tissue, some existing anti-inflammatory drugs can not fundamentally solve the inflammation, on the contrary, it will make the condition worse It is dangerous, complicated, and difficult to treat. There are many types of anti-inflammatory ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K35/644A61P1/02A61P11/04A61P29/00A61P31/00A61P17/10A61K31/525A61K31/375A61K31/315A61K31/573
CPCA61K31/525A61K31/375A61K31/573A61K31/7048A61K33/30A61K35/644A61K2300/00
Inventor 张东承
Owner 张东承
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products